Cholestasis: Exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies

L Yu, Y Liu, S Wang, Q Zhang, J Zhao, H Zhang… - Gut …, 2023 - Taylor & Francis
Cholestasis is a condition characterized by the abnormal production or excretion of bile, and
it can be induced by a variety of causes, the factors of which are extremely complex …

Efficacy and safety of elafibranor in primary biliary cholangitis

KV Kowdley, CL Bowlus, C Levy… - … England Journal of …, 2024 - Mass Medical Soc
Background Primary biliary cholangitis is a rare, chronic cholestatic liver disease
characterized by the destruction of interlobular bile ducts, leading to cholestasis and liver …

Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target

CE Trussoni, SP O'Hara, NF LaRusso - Seminars in immunopathology, 2022 - Springer
The cholangiopathies are a group of liver diseases that affect cholangiocytes, the epithelial
cells that line the bile ducts. Biliary atresia (BA), primary biliary cholangitis (PBC), and …

The causal effects of inflammatory bowel disease on primary biliary cholangitis: A bidirectional two‐sample Mendelian randomization study

H Zhang, L Chen, Z Fan, G Lv - Liver International, 2023 - Wiley Online Library
Background Observational studies have indicated that the incidence of primary biliary
cholangitis (PBC) is higher in inflammatory bowel disease (IBD) patients than that in healthy …

[PDF][PDF] Immunologic responses and the pathophysiology of primary biliary cholangitis

R Chen, R Tang, X Ma, ME Gershwin - Clinics in Liver Disease, 2022 - Elsevier
Primary biliary cholangitis (PBC) is an autoimmune liver disease with striking female
predisposition, and selective destruction of intrahepatic small bile ducts leading to non …

Primary biliary cholangitis: primary autoimmune disease or primary secretory defect

A Floreani, D Gabbia, S De Martin - Expert Review of …, 2023 - Taylor & Francis
Introduction Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease
characterized by the immune-mediated destruction of small and medium intrahepatic bile …

[HTML][HTML] Peripheral helper T cells in human diseases

X Zou, F Huo, L Sun, J Huang - Journal of Autoimmunity, 2024 - Elsevier
Peripheral helper T cells (Tph) are a specialized subset of CD4+ T cells with the ability to
help B cells and induce antibody production. Although usually located in ectopic lymphoid …

Hirsutella sinensis mycelium polysaccharides attenuate the TGF-β1-induced epithelial-mesenchymal transition in human intrahepatic bile duct epithelial cells

M Yang, L Rong, X Zhang, G Li, Q Wang, C Li… - International Journal of …, 2024 - Elsevier
Hirsutella sinensis is the anamorph of Ophiocordyceps sinensis, and its mycelia has been
used to effectively treat a variety of hepatobiliary diseases in clinical practice. In the present …

Elucidation of pericholangitis and periductal fibrosis in cholestatic liver diseases via extracellular vesicles released by polarized biliary epithelial cells

K Maki, T Katsumi, T Hanatani… - … of Physiology-Cell …, 2024 - journals.physiology.org
Cholestatic liver diseases causes inflammation and fibrosis around bile ducts. However, the
pathological mechanism has not been elucidated. Extracellular vesicles (EVs) are released …

[HTML][HTML] Endothelin receptor B enhances liver injury and pro-inflammatory responses by increasing G-protein-coupled receptor kinase-2 expression in primary biliary …

G Xu, Y Gong, F Lu, B Wang, Z Yang, L Chen, J Min… - Scientific Reports, 2022 - nature.com
Severe diseases like cirrhosis and liver failure can be developed from primary biliary
cholangitis (PBC). Endothelin-2 (EDN2) and endothelin receptor B (EDNRB) are related to …